Accession Number: | 0001077183-19-000230 |
Date: | 2019-12-10 |
Issuer: | NEOGENOMICS INC (NEO) |
Original Submission Date: |
MCKENZIE KATHRYN B
12701 COMMONWEALTH DRIVE
SUITE 9
FORT MYERS, FL 33913
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-12-10 | M | 8,000 | a | $8.03 | 10,273 | direct | ||
COMMON STOCK | 2019-12-10 | S | 8,000 | d | $26.37 | 2,273 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 8.03 | 2019-12-10 | deemed execution date | M | 8,000 (d) | 2019-02-26 | 2023-02-26 | common stock 8,000 | $8.03 | 40,000 | direct | |
STOCK OPTION (RIGHT TO BUY) | 9.07 | 2019-12-10 | deemed execution date | 0 ( ) | 2018-10-18 | 2022-10-18 | common stock 25,000 | $9.07 | 25,000 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 19.6 | 2019-12-10 | deemed execution date | 0 ( ) | 2020-03-01 | 2024-03-01 | common stock 13,894 | $19.60 | 13,894 | direct |
ID | footnote |
---|---|
f1 | on february 26, 2018, ms. mckenzie was granted an option to purchase 48,000 shares of neogenomics, inc. common stock. the options vest ratably over the first three anniversary dates of the grant date. |
f2 | on october 18, 2017, ms. mckenzie was granted an option to purchase 25,000 shares of neogenomics, inc. common stock. the options vest ratably over the first three anniversary dates of the grant date. |
f3 | on march 1, 2019, ms. mckenzie was granted an option to purchase 13,894 shares of neogenomics, inc. common stock. the options vest ratably over the first four anniversary dates of the grant date. |